In just 35 days, it’ll be 100% legal for Canadians to BUY cannabis in Canada’s retail stores.

And one popular pot stock ETF could jump 57% by legalization day on Oct. 17.

Here’s the best news . . .

A select group of “pot stocks” could get bought out at HUGE premiums – handing investors big overnight gains.

My urgent briefing reveals important details (click here).

Right now, we’re in the midst of a NEW bull market for “pot stocks.”

Late 2017 was the last time we saw this type of bullish move. Just check out this chart of the pot stock ETF, Horizons Marijuana ETF (TSE: HMMJ).

pot stock ETF

That chart is a thing of beauty…

We’re talking about total gains of 159% in just four months!

Now, I’m expecting a similar move for the Horizons Marijuana ETF, another pot stock ETF, between the Aug. 14 lows and Oct. 17 when Canada legalizes cannabis.

Why?

Frankly, it’s because Canada and California are strikingly similar (click here for the full story).

America’s largest state and our neighbor to the north have similar populations. Canada clocks in at 36 million, and California boasts 39 million.

Meanwhile, both Canada and California have high usage of cannabis. And independent estimates suggest each market could be valued at around $10 billion per year.

Click here to access my top “pot stocks” to BUY NOW.

So, what’s next for pot stocks?

Since the Aug. 14 lows, the marijuana ETF is up 64%.

But if we see sizeable move for this market – like we saw in 2017…

That suggests another 57% gain from these levels.

Now, you could just buy shares of “HMLSF” – that’s the U.S. symbol for the Horizons Marijuana ETF.

Or you could cash in bigger profits . . .

With the Marijuana Buyout Boom Part II

That’s because a select group of companies are holding secret discussions with Fortune 500 companies.

Rumors suggest that Johnson & Johnson (NYSE: JNJ) and Diageo (NYSE: DEO) are actively looking to form strategic partnerships with top Canadian cannabis companies . . .

With deals that would include sizable equity investments.

Now, we’ve already seen Constellation Brands (NYSE: STZ) invest $4 billion in Canopy Growth (NYSE CGC).

Plus, Novartis (NYSE: NVS) is partnering with Tilray (NASDAQ: TLRY) to develop cannabis-based pharmaceuticals.

Now’s the time to BUY shares of the next companies that will get bought out.

Just five stocks are at the top of my BUY LIST.

Go here now for urgent details.

Yours in Profits,

Ian Wyatt

P.S. Why are you waiting?

Some folks are making 463% in less than two months!

Act now… Or you’ll miss out on this year’s bull market move. Click here ASAP.

Published by Wyatt Investment Research at